Resolving inflammatory pain
Nature Medicine
April 12, 2010
Resolvins, naturally-occurring lipids derived from omega-3 fatty acids, may represent a new class of painkillers for treating inflammatory pain, suggests a report published online this week in Nature Medicine. The scientists propose that resolvins may prove effective as analgesics by reducing inflammation and acting in the spinal cord to prevent chronic pain.
Inflammatory pain, such as arthritic and post-operative pain, is triggered by tissue injury, leading to the release of compounds that increase inflammation and act within the spinal cord to cause persistent pain.
Ru-Rong Ji and colleagues found that two resolvins, RvE1 and RvD1, which are naturally produced from certain omega-3 fatty acids, reduce inflammatory pain symptoms when administered to mice. The team showed that RvE1 was 10,000 times more potent at alleviating pain than its parent compound; moreover, an artificial compound, Chemerin, which binds to the same receptor as RvE1 and RvD1 also significantly reduced pain symptoms. Aside from their established anti-inflammatory effects, they also found that RvE1 acts in the spinal cord to prevent persistent neuronal activation which normally causes chronic pain. These analgesic effects were seen without any alterations in normal sensitivity to pain.
doi: 10.1038/nm.2123
Research highlights
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports
-
Jun 16
Microbiology: DNA analysis indicates origins of the Black DeathNature